Home Stock

Stock Research: Aspen Pharmacare

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Aspen Pharmacare

JSE:APN ZAE000066692
19
  • Value
    98
  • Growth
    16
  • Safety
    Safety
    39
  • Combined
    55
  • Sentiment
    6
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Aspen Pharmacare Holdings Limited is a global pharmaceutical company. It focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets, including the key brands Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine. Aspen Pharmacare Holdings Limited operates in South Africa and other global markets. In the last fiscal year, the company had a market cap of $2,813 million, profits of $1,070 million, revenue of $2,458 million, and 8,867 employees.

more
Strongest Rank Market Pulse
Weakest Rank Price vs. Earnings (P/E)
Country South Africa
Industry Pharmaceuticals
Size Medium
Website aspenpharma.com
Index
Good Governace Growth Markets
JSE All Shares
Aspen Pharmacare stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 91 99 89
Growth
16 27 45 77
Safety
Safety
39 39 41 7
Sentiment
6 71 90 55
360° View
360° View
19 65 88 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
20 73 79 46
Opinions Change
21 23 72 50
Pro Holdings
n/a 80 73 26
Market Pulse
5 70 42 81
Sentiment
6 71 90 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 91 99 89
Growth
16 27 45 77
Safety Safety
39 39 41 7
Combined
55 53 75 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
100 97 93 81
Price vs. Earnings (P/E)
89 77 82 78
Price vs. Book (P/B)
93 89 91 91
Dividend Yield
88 82 81 76
Value
98 91 99 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
34 26 54 78
Profit Growth
55 39 48 76
Capital Growth
19 45 21 21
Stock Returns
5 39 79 79
Growth
16 27 45 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
20 24 34 36
Refinancing
95 88 90 1
Liquidity
21 24 28 24
Safety Safety
39 39 41 7

Similar Stocks

Discover high‑ranked alternatives to Aspen Pharmacare and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Motus Holdings

JSE:MTH
Country: South Africa
Industry: Automotive Retail
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews